Softwr

Research · head to head

LabVantage vs Zappi

LabVantage logo

LabVantage

Research

Enterprise LIMS with integrated ELN and biobanking capability

From
On request
Rated
-
Zappi logo

Zappi

Research

Automated consumer insights platform for testing advertising, product concepts and brand health

From
On request
Rated
-

The short version

  • Each has a real cost: LabVantage enterprise implementation weight, with configuration and validation measured in many months; Zappi nothing is published: pricing is a platform subscription plus a prepaid credit bundle quoted per customer, so a buyer cannot benchmark the cost against agency research without going through sales.
  • They diverge on capability: LabVantage covers Unified platform, Zappi covers Validated study templates.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which LabVantage and Zappi actually diverge.

Attributes where LabVantage and Zappi differ
AttributeLabVantageZappi
PlatformsWeb, Cloud, On-premiseWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LabVantage

  • Unified platform
  • Biobanking
  • Instrument integration
  • Industry accelerators
  • Regulatory compliance
  • Web architecture

Only in Zappi

  • Validated study templates
  • Respondent panel access
  • Normative benchmarks
  • Creative testing
  • Brand health tracking
  • AI analysis over history
  • Unlimited users
  • Exports and integrations

What people use each for

The jobs each tool is most often brought in to do.

LabVantage

  • Laboratories wanting LIMS and ELN from one vendor rather than integrating twonot Zappi
  • Biobanks managing specimen provenance, consent and long-term storagenot Zappi
  • Pharmaceutical research organisations spanning discovery through QCnot Zappi
  • Multi-site laboratory networks standardising on a single platformnot Zappi

Zappi

  • A beverage brand screening thirty flavour concepts before committing to two for consumer testingnot LabVantage
  • A marketing team pre-testing three advertising edits in a day so a media booking deadline can be metnot LabVantage
  • An insights function replacing repeated ad-hoc agency studies with a comparable, accumulating body of test resultsnot LabVantage
  • A brand manager running continuous brand health tracking without negotiating a separate tracker contract each yearnot LabVantage

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LabVantage

  • Enterprise implementation weight, with configuration and validation measured in many months
  • Pricing is quote-based with no public entry point
  • The unified platform argument only pays off for laboratories that genuinely need all four capabilities; those needing only LIMS may find focused competitors better
  • Smaller installed base than LabWare, which matters in conservative laboratory procurement
  • Industry accelerators shorten implementation but do not remove the need for laboratory-specific configuration

Zappi

  • Nothing is published: pricing is a platform subscription plus a prepaid credit bundle quoted per customer, so a buyer cannot benchmark the cost against agency research without going through sales.
  • Credits are prepaid against a forecast of the year ahead, which means a team that overestimates research volume ends the year having paid for studies it never ran.
  • The template model that makes studies fast also constrains them; a research question that does not fit a validated instrument either gets forced into one or goes to an agency anyway.
  • Normative benchmarks are strongest in fast-moving consumer goods categories where Zappi has depth, and thinner in business-to-business, financial services and niche categories, where the comparison numbers mean less.
  • Because respondents come from Zappi-sourced panels, sample composition is a vendor decision rather than yours, and any team that needs a bespoke recruitment specification or a low-incidence audience will find the automated route unsuitable.

Pricing, plan by plan

LabVantage

On request
  • LabVantage$undefined/year
    • LIMS
    • ELN
    • LES

Zappi

On request
  • Premium$undefined/year
    • Platform subscription with unlimited users
    • Access to all research solutions
    • Credit bundle scoped to annual research volume
  • Enterprise$undefined/year
    • Platform subscription with unlimited users
    • Multi-market and global organisation controls
    • Connected insights across markets and brands

Which should you pick?

Choose LabVantage if

  • You need unified platform.
  • You work on Web, Cloud, On-premise.
  • You also want biobanking.

Choose Zappi if

  • You need validated study templates.
  • You also want respondent panel access.

Questions people ask

Is LabVantage or Zappi better?
Neither clearly leads. LabVantage starts at On request and Zappi at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LabVantage or Zappi?
LabVantage starts at On request and Zappi at On request.
Does LabVantage or Zappi run on more platforms?
LabVantage runs on Web, Cloud, On-premise. Zappi runs on Web.
What is LabVantage best used for?
LabVantage is most often used for laboratories wanting lims and eln from one vendor rather than integrating two, biobanks managing specimen provenance, consent and long-term storage, pharmaceutical research organisations spanning discovery through qc, multi-site laboratory networks standardising on a single platform. Of those, laboratories wanting lims and eln from one vendor rather than integrating two and biobanks managing specimen provenance, consent and long-term storage are not what Zappi is typically brought in for.
What can LabVantage do that Zappi cannot?
LabVantage covers Unified platform, Biobanking, Instrument integration, Industry accelerators. Zappi covers Validated study templates, Respondent panel access, Normative benchmarks, Creative testing.

Answered from the vendors’ own pages

LabVantage: What does the unified platform actually mean?

LIMS, electronic laboratory notebook, laboratory execution and scientific data management as one product. Laboratories that would otherwise integrate and validate four vendors avoid that work.

Zappi: Does Zappi publish prices?

No. It publishes the structure, a platform subscription plus credits plus optional services, but not the numbers.

LabVantage: Is biobanking really different?

Yes. Specimen provenance, consent tracking and decades-long storage are distinct from test result management, and the number of platforms handling them properly is small.

Zappi: How fast do results come back?

Automated tests typically return within hours to a day, which is the main reason teams choose it over a commissioned study.

LabVantage: What does it cost?

Not published. Enterprise annual licensing plus implementation, quoted on scope.

Zappi: Do we still need an agency?

For standard concept, creative and brand tests, usually not. For bespoke methodologies and hard-to-reach audiences, yes.

LabVantage: Do the industry accelerators shorten implementation?

They help by supplying pre-configured workflows for a vertical. They do not remove laboratory-specific configuration or, in regulated settings, validation.

Zappi: Is there a per-seat charge?

No. Both published tiers include unlimited users; the variable cost is research credits.

LabVantage: How does it compare to LabWare?

LabWare has the larger installed base and deeper pharmaceutical QC dominance. LabVantage argues on the unified LIMS and ELN platform and on biobanking. Both are enterprise projects.

Share

Related pages

Other head to heads